The skin of atopic dermatitis (AD) patients has a high susceptibility to Staphylococcus aureus colonization, and the toxins produced by S. aureus may aggravate AD by acting as superantigens. Objective: The purpose of this study was to evaluate the relationship of the skin barrier function, colonization of S. aureus, and the clinical severity of AD. We also examined the predominant toxin genes produced in Korean AD patients. Methods: Thirty-nine patients with AD were evaluated for clinical severity and skin barrier function by using Severity Scoring of Atopic Dermatitis (SCORAD) index and transepidermal water loss (TEWL). S. aureus was isolated from the forearm, popliteal fossa, and anterior nares of AD patients (n=39) and age-matched controls (n=40); the toxin genes were analyzed by performing multiplex polymerase chain reaction. Results: TEWL showed a statistically significant correlation with clinical severity in patients with AD (p＜0.05). TEWL was correlated with the number of S. aureus colonization sites and the presence of nasal colonization, but these results were not statistically significant. S. aureus strains were isolated in 64.1% of the 39 AD patients. The SCORAD index and AD severity were strongly correlated with the number of colonization sites.
INTRODUCTION
Atopic dermatitis (AD) is a chronic, relapsing and pruritic skin disease that occurs most commonly during early infancy and childhood. It is a multifactorial disease that is caused by the interaction of various factors, such as genetic background, allergic and immunologic abnormalities, pharmacologic and physiologic factors, environmental factors, and skin barrier defects. Its prevalence has recently been increasing at up to 10 to 20% of children and 1 to 3% of adults in industrialized countries 1 .
Recent genetic studies have demonstrated that defective skin barrier function is an important factor in the pathogenesis of AD 2, 3 . Several studies have shown that trans- epidermal water loss (TEWL), which may represent skin barrier function, was increased in AD patients compared to those of the normal control group 4, 5 .
On the other hand, the role of Staphylococcus aureus in the pathogenesis of AD is currently receiving attention. Actually, 90% of the skin of AD patients has shown colonization with S. aureus, and the number of S. aureus colonies in the sample from AD patients was significantly higher than those of normal controls 6 . Nasal colonization of S. aureus in infants with AD was also associated with the prevalence and clinical severity of AD 7 .
The theory that the toxin produced by S. aureus exacerbates the disease activity of AD has been widely accepted, yet various rates of detecting toxin genes or commonly related genes have been reported by many researchers.
In the present study, we evaluated TEWL according to the clinical severity of AD, and we also examined the relationship between the clinical severity of AD and the colonization rates of S. aureus on the skin and the anterior nares. We also investigated the common toxin genes that are involved in the pathogenesis of AD in Korea.
MATERIALS AND METHODS

Study populations
From June to August 2009, we acquired patients with AD and normal control group participants through an advertisement. All 39 patients with AD, according to the accepted diagnostic criteria in Korea 8 , were enrolled and compared with healthy controls of a similar age (n=40). Those patients had no other systemic disease, no recent history of taking antibiotics and immunosuppressants for the month before the study, and no history of invasive infections, such as erysipelas and cellulitis. Voluntary informed consent in written form was obtained from all participants and/or legal guardians, and all the study protocols were reviewed and authorized by the Gil Hospital Institutional Review Board.
Scoring in atopic dermatitis (SCORAD) index
The AD severity was assessed by using Severity Scoring of Atopic Dermatitis (SCORAD) index 9 .
Measurement of TEWL
TEWL was measured using a TEWAmeter TM210 Ⓡ (Courage & Khazaka, Cologne, Germany) for the evaluation of the skin barrier function. Before a measurement, the patient was made comfortable with exposing the examination site by sitting in a silent, draft-free, and direct light-free room at normal temperature for 10 minutes. The examination site was the most severe lesion, usually the antecubital area or popliteal fossa, as chosen by the same dermatologist who examined all the subjects. The measurement was performed for 1 minute.
Isolation of S. aureus from the skin and anterior nares
To culture and separate S. aureus, we used transport media (Micromedia, Busan, Korea). The samples were taken from the antecubital area, the popliteal fossa, and the nasal mucosa, using sterile cotton tips. Within 24 hours, the sample was incubated on mannitol salt agar for 48 hours, and a single colony was pure-cultured and used for further experiments. 
Detection of S. aureus-derived exotoxins
We performed multiplex PCR, as described by Breuer et al. 10 , to detect the staphylococcal toxin genes carried by the S. aureus strains: staphylococcal enterotoxins sea, seb, sec, sed, and see and toxic shock syndrome toxin (tsst)-1. All primers were supplied by MWG Biotech (Ebersberg, Germany), and are shown in 
Statistical analysis
The statistical package for the social sciences (SPSS Version 12.0; SPSS Inc., Chicago, IL, USA) was used for all analyses. 
RESULTS
Characteristics of the subjects
AD patients consisted of 18 males and 21 females (age: 1 ∼40 years, median: 11.8 years). We classified the SCORAD index as follows: less than 25 as mild, 25∼49 as moderate, and more than 50 as severe. The number of patients and their features are summarized in Table 3 . The normal control group included 40 individuals (16 males and 24 females, age range: 1∼20 years, median age: 10 years).
Differences of TEWL according to clinical severity of AD
The mean TEWL (g/m 2 per hour), according to the severity of AD was 30.95 in mild, 37.00 in moderate, and 67.55 in severe patients. TEWL showed a statistically significant correlation with the clinical severity of AD (Fig. 1, p= 0.002).
Difference of S. aureus colonization rates between AD patients and normal controls
Of the 39 patients, 25 patients (64.1%) had S. aureus on one or more sites of the skin. The mean colonization rates for AD patients were 25.6% on the antecubital area, 35.8% on the popliteal fossa, and 46.1% on the anterior nares. The overall mean colonization rate for the normal controls was 20%, and the anterior nares colonization rates of the normal controls were 17.5%. The results of the normal control subjects were lower than those of the AD patients, but the differences were not statistically significant (Table 4) . Sixty-five percent of patients (13/20), who had S. aureus isolated from the anterior nares, also had S. aureus on the skin. Of 8 patients with S. aureus isolated from both the skin and anterior nares, 6 patients had the same toxins.
Differences of TEWL according to the number of S. aureus colonization sites in each of the severity groups
For the relationship of TEWL and the number of colonization sites, we found that the greater the number of colonization sites, the higher the TEWL (Fig. 2) . However, this was not statistically significant (p＞0.05). Values are presented as number (%). Sea: staphylococcal enterotoxin a, tsst-1: toxic shock syndrome toxin-1. 
Differences of TEWL according to nasal colonization of S. aureus in each of the severity groups
For the relationship of TEWL and the colonization of the anterior nares, positive colonization of the anterior nares showed higher TEWL than the negative colonization in each of the groups (Fig. 3) . However, these were not statistically significant (p＞0.05).
Difference of colonization of S. aureus according to the SCORAD index of AD patients
For the relationship of colonization of S. aureus and the SCORAD index, we found that the higher SCORAD index group had more colonization of S. aureus. However, this was not statistically significant (p＞0.05, Table 5 ).
Toxin gene analysis of S. aureus in AD patients
S. aureus was isolated from 19 patients, and there were 32 total samples from the skin or the anterior nares. Among them, nuc was identified in all, except one sample, and mecA was not produced. Of the 19 patients with S. aureus, the predominant toxin gene was sea only in 10 patients, and the others were in co-existence with sea and tsst-1 in 8 patients and tsst-1 only in 1 patient (Table 6) . Of the 8 patients who had S. aureus on both the skin and nasal mucosa, 6 patients had the same toxin genes identified on both areas.
DISCUSSION
The clinical expression of AD is the result of the complex interaction of environmental factors and skin barrier dysfunction, susceptibility genes, and immunologic abnormalities. In recent years, an impaired skin barrier function has been receiving attention as one of the important factors in the pathogenesis of AD. Normally, the skin barrier has roles as a permeability barrier, which guards against excessive water loss, and an immunologic barrier, which prevents the entry of harmful substances from the environment such as irritants, allergens, and micro-organisms 9 . However, a disturbed skin barrier causes the entry of various bacteria and viruses and hypersensitivity reactions, as well as abnormal immunologic reactions against micro-organisms and secondary infection 6, 9 .
More than 90% of AD patients have S. aureus as the most common cutaneous infection. In contrast, S. aureus can be found on the skin of only 5% of healthy individuals 9, 10 .
The increased level of S. aureus on AD patients is likely the result of combined processes, which includes altered lipid composition within the stratum corneum, exposed extracellular matrix adhesins, a defective immune response, bacterial superantigens, and increased specific immunoglobulin E production 9 .
In our study, TEWL was significantly increased according to the clinical severity of AD. We also observed that TEWL was increased with an increased number of colonization sites in each of the clinical severity group, and nasal mucosa of adult AD patients, and they isolated S. aureus from 94% of AD patients. Of these patients, S. aureus was isolated on both the skin and nasal mucosa in 77.3%; however, 10.6% and 6.1% of AD patients had S. aureus isolated on the skin and nasal mucosa only, respectively. These results led to the hypothesis that the nose may be an important reservoir of S. aureus strains that are spread over the surface of the skin by autotransmission. They performed toxin gene analyses of S. aureus strains, isolated from the skin and anterior nares of 10 patients, and found that the nasal and cutaneous strains produced the same toxins in most cases, results which support this hypothesis. In our results, S. aureus was isolated from 64.1% of AD patients (25/39), and this colonization rate was lower than the previously reported high colonization rates in atopic skin 11 . The reasons for lower colonization compared to other studies are geographical difference and a difference in the composition of the patients' group--we included AD patients with less severe disease because we gathered the patients through an advertisement and did not include AD patients from the out-patient clinics. However, the colonization rate of S. aureus was strongly related to AD severity and the SCORAD index. We also observed that 65% of the patients (13/20) who had S. aureus isolated from the anterior nares also had S. aureus on the skin. Of the 8 patients with S. aureus isolated from both the skin and anterior nares, 6 had the same toxins; therefore, our results corresponded with those of Breuer et al. 11 .
Indeed, S. aureus colonization is both a cause and a consequence of allergic skin inflammation in AD. There are several reports about the colonization of S. aureus in AD in several countries (Table 7) 12-18 . Each study reported various colonization rates of S. aureus and various dominant toxins of S. aureus. The difference in the predominant toxin carried by the S. aureus strains isolated from AD patients between the reports could be associated with different geographic regions 14 . In our study, the colonization rate was 64.1% (25/39), and sea was frequently detected. This result was similar to other studies on Korean people 14, 17 . We did not perform the assay for exfoliative toxins.
In conclusion, we ascertained the correlation between skin barrier function and the clinical severity of AD, and we observed that TEWL was increased with increasing colonization sites and positive colonization of the nasal mucosa in each clinical severity group. S. aureus was isolated from 64.1% of the AD patients (25/39). The rate of colonization of S. aureus was related to the SCORAD index. According to these results, we may assume that colonization of S. aureus and damage of skin barrier function may be important factors in the development and aggravation of AD. The colonization of S. aureus on the nasal mucosa was double that of the antecubital area and popliteal fossa, and 65% of AD patients with nasal colonization also showed colonization on the skin. In addition, the same toxins were detected in 6 of the 8 patients who had S. aureus on both the nasal mucosa and skin. These results imply that the nasal mucosa may be the major reservoir of S. aureus strains. The most common toxin gene was sea in our Korean AD patients, which is similar to that of other studies performed in Korea. Therefore, sea may be an important factor in the pathogenesis of AD in Korean patients, and further investigation should be done on the role of superantigens in the pathogenesis in AD.
